Breakpoints

#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials

Dec 23, 2022
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 3min
2
A Gamecock's Life Is Laying Out in Front of Me
02:44 • 3min
3
The ID Week Podcast - The Biggest to the Smallest.
05:46 • 3min
4
The Eradicate Trial for Staff Arias Bacteremia
09:13 • 2min
5
MICs and Bacteremia
11:09 • 4min
6
Septobiprols - What's Next?
15:17 • 2min
7
COVID-19 - What's the Difference Between Stewardship and Clinical Care?
17:14 • 4min
8
Preventing CMV Disease and CMV High Risk in Solid Organ Transplants
21:32 • 5min
9
Valgan Cycle of Your Isn't a Med That's Necessarily Easy to Access.
26:05 • 2min
10
PKPD Target Achievement Work for Soul Back, Damn Delore Back, Damn, Damn
27:35 • 5min
11
Hiv Aids
32:18 • 4min
12
Acute Kidney Injuries in AIDS Patients in Brazil
36:38 • 4min
13
Antiretroviral Therapy
40:58 • 2min
14
HIV AIDS - Is the Nader CD4 Cell Count What Matters?
43:20 • 4min
15
C Diff - What's Next?
47:48 • 2min
16
SDR 109
49:57 • 2min
17
SCR 109 and C. Diff
52:11 • 5min
18
Jepot Is a Novel First in Class Agent
57:00 • 4min
19
Is This an Uncomplicated UTI Agent?
01:01:04 • 3min
20
E-Petroboryl, A&2 Therapeutics
01:04:16 • 2min
21
Cepheum Tannibor Bactam
01:06:40 • 4min
22
ABX01 - A Novel Immunotherapy to Treat Gram Negative Infections
01:10:40 • 5min
23
Breakpoints - ID Week Recap
01:15:11 • 2min